Myriad Genetics, Inc. (MYGN) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Myriad Genetics, Inc. (MYGN)

An SI Board Since August 1996

Posts	SubjectMarks	Bans	Symbol
2355	65	0	MYGN

Emcee: s myers	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
680	Thanx. Maybe I can spur my editor to publish the piece which I've been paid	Jill	-	3/6/2005
679	There was an article in Science last year. I'll see if I can dig it up. The	Biomaven	-	3/6/2005
678	Where can I go to learn more about which drug companies are using bayesian trial	Jill	-	3/6/2005
677	Yes - I agree with you. But the issue is the FDA. Up to now, as far as I know, t	Biomaven	-	3/6/2005
676	OT Bayesian Statistics. You would have an opportunity to cut the trial short if	A.J. Mullen	-	3/6/2005
675	<i>I don't know why there are not more bayesian trials. Analyse n subj	Biomaven	-	3/5/2005
674	Silicon Investor is a good place to make such contacts. However, this <b>	scaram(o)uche	-	3/5/2005
673	HELLO Richard Harmon I AM NEW and I WANT TO ENTER AMERICAN STOCK MARKET, to have	BENIBMV	-	3/5/2005
672	HELLO I AM NEW IN THIS FORUM I WANT TO KNOW THAT VALUE I CAN BUY	BENIBMV	-	3/5/2005
671	tcpalm.com Cheap at-home genetic testing opens deep Pandora's box By Paul E	scaram(o)uche	-	3/5/2005
670	they slip these things in late sometimes..... 44,451 shares at 22.346, 17:15.	scaram(o)uche	-	3/4/2005
669	going against the old hard core of biotech's 9/11 whores, we get the pleasur	scaram(o)uche	-	3/4/2005
668	You didn't get a million, but you got comfortably above the 60 day average v	tom pope	-	3/4/2005
667	supplemented with posts at yahoo which I imagine you've seen, my position is	scaram(o)uche	-	3/4/2005
666	>>note.... one recent webcast, forget which one..... they're also cons	keokalani'nui	-	3/4/2005
665	no, abstracts are due up soon.... a week or two. the first phase I only launc	scaram(o)uche	-	3/4/2005
664	would love to see volume way up today..... would love to see us push a milli	scaram(o)uche	-	3/4/2005
663	Thanks Rick.. fascinating stuff...They mention in the PR that this is their 2nd	zeta1961	-	3/4/2005
662	>> your thoughts on this molecule << The blood brain barrier news i	scaram(o)uche	-	3/4/2005
661	Rick..this made it into my brain tumor news feed..old to you but new to me? you	zeta1961	-	3/4/2005
660	From my JP Morgan notes: 90% to see 45% effect P of 0.01. I suppose that means	A.J. Mullen	-	3/3/2005
659	>> What value do you attribute to PM? << In an infrastructure that	scaram(o)uche	-	3/3/2005
658	Market cap $680m. What value do you attribute to PM? I give it $200m. 12x nex	keokalani'nui	-	3/3/2005
657	Wilder.... I don't care about end points. A decent and safe drug would do	scaram(o)uche	-	3/3/2005
656	Rick, Sorry to bother you. I'm trying to make sense of the AD endpoints, w	keokalani'nui	-	3/3/2005

Go to reply# or date (mm/dd/yy):